palmidrol has been researched along with Chronic Kidney Diseases in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Impellizzeri, D | 1 |
| Esposito, E | 1 |
| Attley, J | 1 |
| Cuzzocrea, S | 1 |
1 review available for palmidrol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD).
Topics: Amides; Animals; Anti-Inflammatory Agents; Endocannabinoids; Ethanolamines; Humans; Oleanolic Acid; | 2014 |